In vitro micropropagation of Jasminum grandiflorum L.
DOI:
https://doi.org/10.3329/bjsir.v53i4.39191Keywords:
in vitro regeneration, mass propagation, Jasminum grandiflorum and explantAbstract
An efficient protocol was developed for in vitro plant regeneration of Jasminum grandiflorum L. The highest elongated shoots (60%) were achieved from axillary meristems using MS (Murashige and Skoog ) basal medium supplemented with 1 mg/l 6-benzyladenine (BAP) and 60 mg/l coconut water. After adding 1.0 mg/l BAP and 45 mg/l coconut water in the culture medium, the highest rate of shoot proliferation was exhibited after 4 weeks of culture. Rooting was found within 14-23 days after the cut end of shoots was soaked in 1.5 mg/l IBA solution for 3-7 minutes. The regenerated healthy rooted plantlets were transferred to small plastic pot containing garden soil and compost in a ratio of 2:1. Maximum (75%) in vitro rooted plants were survived in the shade house and finally survived naturally in soil condition. The successful protocol for in vitro regeneration was developed which will facilitate the conservation and propagation of the important medicinal plant.
Bangladesh J. Sci. Ind. Res.53(4), 277-282, 2018
Downloads
45
37
Downloads
Published
How to Cite
Issue
Section
License
Bangladesh Council of Scientific and Industrial Research (BCSIR) holds the copyright to all contents published in Bangladesh Journal of Scientific and Industrial Research (BJSIR). A copyright transfer form should be signed by the author(s) and be returned to BJSIR.
The entire contents of the BJSIR are protected under Bangladesh Council of Scientific and Industrial Research (BCSIR) copyrights.
BJSIR is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC) Creative Commons Attribution-NonCommercial 4.0 International License which allows others remix, tweak, and build upon the articles non-commercially, and although their new works must also acknowledge and be non-commercial, they dont have to license their derivative works on the same terms.
